Review of Antiretroviral Therapy in the Prevention of HIV-Related AIDS Dementia Complex (ADC)
- 1 January 1995
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 49 (1) , 25-31
- https://doi.org/10.2165/00003495-199500491-00007
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Cerebrospinal fluid human immunodeficiency virus type 1 (HIV‐1) p24 antigen levels in HIV‐1–related dementiaAnnals of Neurology, 1994
- Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIVAIDS, 1993
- A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Neuropathological evidence that zidovudine reduces incidence of HIV infection of brainThe Lancet, 1991
- Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.BMJ, 1989
- Neuropsychological Outcome of Zidovudine (AZT) Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1988
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- CT, MR, and pathology in HIV encephalitis and meningitisAmerican Journal of Roentgenology, 1988
- Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudineAIDS, 1988
- RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINEThe Lancet, 1987